中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共3条，第1-3条 帮助

已选(0)清除 条数/页：   排序方式：
High chromosome instability identified by low-pass whole-genome sequencing assay is associated with TP53 copy loss and worse prognosis in BRCA1 germline mutation breast cancer 期刊论文
BREAST CANCER, 2021
作者:  Zhu, Liang;  Pan, Jia-Ni;  Qian, Ziliang;  Ye, Wei-Wu;  Wang, Xiao-Jia;  Cao, Wen-Ming
收藏  |  浏览/下载：61/0  |  提交时间：2021/09/06
CIN  TP53  BRCA1  LPWGS  Breast cancer  
Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2-Breast Cancer Patient With High Tumor Mutational Burden 期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 10
作者:  Wang, Rong;  Yang, Yuchen;  Ye, Wei-Wu;  Xiang, Jianxing;  Chen, Songan;  Zou, Wei-Bin;  Wang, Xiao-Jia;  Chen, Tianhui;  Cao, Wen-Ming
收藏  |  浏览/下载：53/0  |  提交时间：2021/04/26
breast cancer  immunotherapy  biomarker  TMB  NGS  molecular monitoring  
Non-Invasive Biomarkers for Early Detection of Breast Cancer 期刊论文
CANCERS, 2020, 卷号: 12
作者:  Li, Jiawei;  Guan, Xin;  Fan, Zhimin;  Ching, Lai-Ming;  Li, Yan;  Wang, Xiaojia;  Cao, Wen-Ming;  Liu, Dong-Xu
收藏  |  浏览/下载：54/0  |  提交时间：2020/12/28
breast cancer  biomarker  diagnosis  detection  blood  body fluid